Study objective: Patients with moderate to severe COPD are frequently
prescribed expensive and complicated therapies that require adjustment
s in usual activities of daily living. However, little is known about
factors that are associated with adherence to such treatment. The obje
ctive of this study was to identify characteristics of patients who we
re adherent to long-term home nebulizer therapy. Design: Patients were
stratified into two adherence groups based on average minutes of nebu
lizer use each day. A logistic regression model was developed to predi
ct adherence based on baseline variables. A questionnaire was administ
ered to patients to assess reasons for adherence to therapy. Setting:
Five clinical centers in the United States and Canada. Participants: N
ine hundred eighty-five patients with moderate to severe COPD enrolled
in the Intermittent Positive Pressure Breathing (IPPB) Trial. Interve
ntions: Long-term home IPPB and nebulizer therapy. Measurements and re
sults: Altogether 50.6% of patients were adherent, and 49.4% were nona
dherent. Among baseline variables, good adherence was predicted by whi
te race, married status, abstinence from cigarettes and alcohol, serum
theophylline level greater than or equal to 9 pg/mL, more severe dysp
nea, and reduced FEV(1) (p<0.05). Subjects who were adherent to nebuli
zer therapy were older, better educated, had a stable lifestyle, were
more likely to report that the therapy made them feel better, and were
more likely to keep clinic appointments. Conclusions: Sociodemographi
c, physiologic, and quality of life variables were associated with adh
erence to long-term nebulizer therapy.